v3.26.3
Loans Receivable and Allowance for Credit Losses
9 Months Ended
Sep. 30, 2026
Loans Receivable and Allowance for Credit Losses [Abstract]  
Loans Receivable and Allowance for Credit Losses Note 6 - Loans Receivable and Allowance for Credit Losses

The following tables present the recorded investment in loans receivable as of September 30, 2026 and December 31, 2025 by segment and class:

September 30, 2026

December 31, 2025

(In Thousands)

Residential one-to-four family

$

214,707

$

226,708 

Commercial and multi-family (1)

1,753,542

2,040,768 

Cannabis related (2)

4,070

69,293 

Construction (1)

13,434

68,521 

Commercial business (1) (3)

126,172

168,459 

Business express

64,503

74,862 

Home equity (4)

72,710

74,332 

Consumer

2,376

3,580 

2,251,514

2,726,523 

Less:

Deferred loan fees, net

(1,547)

(1,741)

Allowance for credit losses

(70,270)

(33,691)

Total Loans, net

$

2,179,697

$

2,691,091 

(1) Excludes Cannabis related loans.

(2) Includes Commercial and multi-family, Construction, and Commercial business loans to borrowers involved in the cannabis industry.

(3) Excludes Business express loans.

(4) Includes Home equity lines of credit.

At September 30, 2026, loans held for sale, which are excluded from the amounts presented above, were comprised of $42.2 million of cannabis-related loans, $13.8 million of commercial and multifamily real estate loans, $10.8 million of construction loans, and $743 thousand of commercial business loans. There were no loans held for sale at December 31, 2025.


‎

Note 6 – Loans Receivable and Allowance for Credit Losses (Continued)

Allowance for Credit Losses

The Company engages a third-party vendor to assist in the current expected credit loss (“CECL”) calculation and has established an internal governance framework to oversee the quarterly estimation process for the allowance for credit losses (“ACL”). The ACL calculation methodology relies on regression-based discounted cash flow (“DCF”) models that correlate relationships between certain financial metrics and external market and macroeconomic variables. Following are some of the key factors and assumptions that are used in the Company’s CECL calculations:
‎

methods based on probability of default and loss given default which are modeled based on macroeconomic scenarios;

a reasonable and supportable forecast period determined based on management’s current review of macroeconomic environment;

a reversion period after the reasonable and supportable forecast period;

estimated prepayment rates based on the Company’s historical experience and future macroeconomic environment;

estimated credit utilization rates based on the Company’s historical experience and future macroeconomic environment; and

incorporation of qualitative factors not captured within the modeled results. The qualitative factors include but are not limited to changes in lending policies, business conditions, changes in the nature and size of the portfolio, portfolio concentrations, and external factors such as competition.


‎
The allowance for credit losses is aggregated for the major loan segments, with similar risk characteristics, summarized below. However, for the purposes of calculating the reserves, these segments may be further broken down into loan classes by risk characteristics that include but are not limited to regulatory call codes, industry type, geographic location, and collateral type.

Residential one-to-four family real estate loans involve certain risks such as interest rate risk and risk of non-repayment. Adjustable-rate residential real estate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default. At the same time, the marketability of the underlying properties may be adversely affected by higher interest rates. Repayment risk may be affected by a number of factors including, but not necessarily limited to, job loss, divorce, illness and personal bankruptcy of the borrower.

Commercial and multi-family real estate lending entails additional risks as compared with one-to-four family residential real estate lending. Such loans typically involve large loan balances to single borrowers or groups of related borrowers. The payment experience on such loans is typically dependent on the successful operation of the real estate project. Loans secured by commercial and multi-family real estate are generally larger and involve a greater degree of risk than one-to-four family residential mortgage loans. The borrower’s creditworthiness, as well as the property’s continued viability and cash flow potential are of primary concern in commercial and multi-family real estate lending. Commercial loans secured by owner occupied properties involve different risks when measured against one-to-four family residential and non-owner-occupied commercial mortgage loans. Cash flow on owner occupied properties is often dependent on the success of the business operation contained within the subject property. The success of such projects is sensitive to changes in supply and demand conditions in the market for commercial real estate as well as general economic conditions.

Cannabis related loans include commercial and multi-family, construction, and commercial business loans to borrowers involved in the cannabis industry and have the risks inherent in such loan types discussed herein in addition to risk inherent in this industry. While medical use cannabis and recreational use businesses are legal in numerous states, including our primary markets of New Jersey and New York, such businesses are not legal at the federal level and marijuana remains a Schedule I drug under the Controlled Substances Act of 1970. Federal prosecutors have significant discretion and there can be no assurance that the federal prosecutors will not choose to strictly enforce the federal laws governing cannabis. Any change in the federal government’s enforcement position could potentially subject our borrowers to criminal prosecution and other sanctions, which would have a material adverse effect on their businesses. Cannabis-related loans present greater repayment and credit risk than similar loans to borrowers outside the cannabis industry. Cannabis-related businesses are generally not able to seek protection under federal bankruptcy law, which may limit a borrower’s ability to reorganize its obligations in the event of financial distress and increases the risk that the Bank will not recover the full amortized cost of a loan upon default. In addition, providing banking services to cannabis-related businesses subjects the Bank to enhanced obligations under the Bank Secrecy Act and related anti-money laundering regulations, including specialized customer due diligence and ongoing monitoring requirements, and the filing of suspicious activity reports specific to marijuana-related accounts. Compliance with these heightened requirements increases the Bank’s operational costs and regulatory risk. These factors, combined with the industry’s sensitivity to state regulatory and pricing volatility, may result in higher loss severities on cannabis-related loans as compared to the Bank’s other loan segments. During the three months ended September 30, 2026, the Company transferred a substantial portion of its cannabis-related loans to held for sale in connection with its planned exit from the cannabis banking business. As a result, cannabis-related lending exposure at September 30, 2026 was significantly reduced compared to prior periods, though we are required to continue to value these assets on our balance sheet at the lower of cost or fair market value as loans held for sale.

Construction lending is generally considered to involve a greater degree of risk compared to other forms of commercial lending due to the concentration of principal in a limited number of loans and borrowers and the effects of the general economic conditions on developers and builders. Moreover, a construction loan can involve additional risks because of the inherent difficulty in estimating both a property’s value at completion of the project and the estimated cost (including interest) of the project. The nature of these loans is such that they are generally difficult to evaluate and monitor. In addition, speculative construction loans to a builder are not necessarily pre-sold and thus pose a greater potential risk to the Bank than construction loans to individuals on their personal residence.

Commercial business lending, including lines of credit, is generally considered higher risk due to the concentration of principal in a limited number of loans and borrowers and the effects of general economic conditions on the business. Commercial business loans are primarily secured by inventories and other business assets. In many cases, any repossessed collateral for a defaulted commercial business loan will not provide an adequate source of repayment of the outstanding loan balance. The Bank has further segregated its commercial business portfolio into commercial business express loans that carry higher risk relative to other commercial business loans. The Bank had originated commercial business express loans to support small business owners coming out of the COVID crisis. The portfolio consists of a large number of loans with a majority of the loans carrying a balance of $250,000 or lower. These loans were generally originated to provide businesses with expedited access to capital. As a result, the loans may involve characteristics that differ materially from the Bank’s traditional commercial business lending activities and may carry a higher risk profile relative to other commercial business loans. In many cases, these loans are unsecured and were underwritten using processes tailored to address borrowers’ immediate liquidity needs, which may not have involved the same level of financial analysis and ability-to-repay assessment typically applied to the Bank’s broader commercial business loan portfolio. Accordingly, this portfolio is subject to heightened repayment risk and may be more vulnerable to adverse economic or borrower-specific developments than the Bank’s traditional commercial business lending portfolio.

Home equity lending entails certain risks such as interest rate risk and risk of non-repayment. The marketability of the underlying property may be adversely affected by higher interest rates, decreasing the collateral value securing the loan. Repayment risk can be affected by job loss, divorce, illness and personal bankruptcy of the borrower. Home equity line of credit lending entails securing an equity interest in the borrower’s home. In many cases, the Bank’s position in these loans is as a junior lien holder to another institution’s superior lien. This type of lending is often priced on an adjustable rate basis with the rate set at or above a predefined index. Adjustable-rate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default.
‎

Note 6 - Loans Receivable and Allowance for Credit Losses (Continued)

Other consumer loans generally have increased credit risk because of the type and nature of the collateral and, in certain cases, the absence of collateral. Consumer loans generally have shorter terms and higher interest rates than other lending. In addition, consumer lending collections are dependent on the borrower’s continuing financial stability and thus are more likely to be adversely affected by job loss, divorce, illness and personal bankruptcy. In many cases, any repossessed collateral for a defaulted consumer loan will not provide an adequate source of repayment of the outstanding loan.

The following tables set forth the activity in the Company’s allowance for credit losses on loans for the three and nine months ended September 30, 2026, and the related portion of the allowance for credit losses that is allocated to each loan class, as of September 30, 2026 (in thousands):

Residential

Commercial & Multi-family (1)

Cannabis Related (2)

Construction (1)

Commercial Business (1)(3)

Business Express

Home Equity (4)

Consumer

Total

Allowance for credit losses:

Beginning Balance, July 1, 2026

$

1,904

$

13,959

$

1,494

$

342

$

16,092

$

10,477

$

697

$

15 

$

44,980

Charge-offs

-

(49,915)

(27,669)

(1,594)

(10,273)

(1,411)

-

-

(90,862)

Recoveries

-

-

-

-

1,106

85

-

-

1,191

Provision (benefit)

665

74,666

26,261

1,663

9,073

2,445

184

4

114,961

Ending Balance, September 30, 2026

2,569

38,710

86

411

15,998

11,596

881

19

70,270

Ending Balance attributable to loans:

Individually evaluated

-

2,016

-

-

897

1,694

-

-

4,607

Collectively evaluated

2,569

36,694

86

411

15,101

9,902

881

19

65,663

Ending Balance, September 30, 2026

2,569

38,710

86

411

15,998

11,596

881

19

70,270

Loans Receivables:

Individually evaluated

2,848

32,564

-

-

3,981

1,694

107

-

41,194

Collectively evaluated

211,859

1,720,978

4,070

13,434

122,191

62,809

72,603

2,376

2,210,320

Total Gross Loans:

$

214,707

$

1,753,542

$

4,070

$

13,434

$

126,172

$

64,503

$

72,710

$

2,376

$

2,251,514

(1) Excludes Cannabis related loans.

(2) Includes Commercial and multi-family, Construction, and Commercial business loans to borrowers involved in the cannabis industry.

(3) Excludes Business express loans.

(4) Includes Home equity lines of credit.

Residential

Commercial & Multi-family (1)

Cannabis Related (2)

Construction (1)

Commercial Business (1)(3)

Business Express

Home Equity (4)

Consumer

Total

Allowance for credit losses:

Beginning Balance, January 1, 2026

$

1,776 

$

12,057 

$

1,477 

$

668 

$

6,676 

$

10,390 

$

632 

$

15 

$

33,691 

Charge-offs

(2)

(52,614)

(27,669)

(1,594)

(17,578)

(3,009)

-

-

(102,466)

Recoveries

-

-

-

-

1,770 

539 

-

-

2,309 

Provision (benefit)

795 

79,267 

26,278 

1,337 

25,130 

3,676 

249 

4 

136,736 

Ending Balance, September 30, 2026

$

2,569 

$

38,710 

$

86 

$

411 

$

15,998 

$

11,596 

$

881 

$

19 

$

70,270 

(1) Excludes Cannabis related loans.

(2) Includes Commercial and multi-family, Construction, and Commercial business loans to borrowers involved in the cannabis industry.

(3) Excludes Business express loans.

(4) Includes Home equity lines of credit.

The increase in the allowance for credit losses on loans during the three and nine months ended September 30, 2026 is primarily due to additional reserves within the commercial and multi-family segment following the Company’s review of that portfolio that concluded in the third quarter of 2026. In addition, for the nine-month period, additional reserves within the commercial business segment were the result of continued credit deterioration within that portfolio.


‎

Note 6 - Loans Receivable and Allowance for Credit Losses (Continued)

The following tables set forth the activity in the Company’s allowance for credit losses on loans for the three and nine months ended September 30, 2025, and the related portion of the allowance for credit losses that is allocated to each loan class, as of September 30, 2025 (in thousands): 

Residential

Commercial & Multi-family (1)

Cannabis Related (2)

Construction (1)

Commercial Business (1)(3)

Business Express

Home Equity (4)

Consumer

Total

Allowance for credit losses:

Beginning Balance, July 1, 2025

$

1,837

$

12,419

$

14,852

$

1,907

$

8,898

$

10,093

$

635

$

17

$

50,658

Charge-offs

-

(79)

(12,756)

-

(3,453)

(1,206)

-

-

(17,494)

Recoveries

9 

-

-

-

2 

548

-

-

559

Provision (benefit)

(219)

(383)

(631)

(243)

6,667

(1,057)

(48)

(6)

4,080

Ending Balance, September 30, 2025

1,627

11,957

1,465

1,664

12,114

8,378

587

11

37,803

Ending Balance attributable to loans:

Individually evaluated

-

3,405

-

262

8,129

2,833

-

-

14,629

Collectively evaluated

1,627

8,552

1,465

1,402

3,985

5,545

587

11

23,174

Ending Balance, September 30, 2025

1,627

11,957

1,465

1,664

12,114

8,378

587

11

37,803

Loans Receivables:

Individually evaluated

302

105,115

-

2,310

18,355

2,833

443

-

129,358

Collectively evaluated

226,838

1,974,973

69,102

103,670

174,407

75,420

73,123

2,042

2,699,575

Total Gross Loans:

$

227,140

$

2,080,088

$

69,102

$

105,980

$

192,762

$

78,253

$

73,566

$

2,042

$

2,828,933

(1) Excludes Cannabis related loans.

(2) Includes Commercial and multi-family, Construction, and Commercial business loans to borrowers involved in the cannabis industry.

(3) Excludes Business express loans.

(4) Includes Home equity lines of credit.

Residential

Commercial & Multi-family (1)

Cannabis Related (2)

Construction (1)

Commercial Business (1)(3)

Business Express

Home Equity (4)

Consumer

Total

Allowance for credit losses:

Beginning Balance, January 1, 2025

$

1,947 

$

10,451 

$

1,613 

$

1,902 

$

10,497 

$

7,769 

$

594 

$

16 

$

34,789 

Charge-offs

-

(419)

(12,756)

-

(5,301)

(9,246)

-

-

(27,722)

Recoveries

43 

-

-

-

6 

871 

-

-

920 

Provision (benefit)

(363)

1,925 

12,608 

(238)

6,912 

8,984 

(7)

(5)

29,816 

Ending Balance, September 30, 2025

$

1,627 

$

11,957 

$

1,465 

$

1,664 

$

12,114 

$

8,378 

$

587 

$

11 

$

37,803 

(1) Excludes Cannabis related loans.

(2) Includes Commercial and multi-family, Construction, and Commercial business loans to borrowers involved in the cannabis industry.

(3) Excludes Business express loans.

(4) Includes Home equity lines of credit.

Note 6 - Loans Receivable and Allowance for Credit Losses (Continued)

The following table sets forth the activity in the allowance for credit losses on loans and amount recorded in loans receivable at and for the year ended December 31, 2025. The table also details the amount of total loans receivable that are evaluated individually and collectively, and the related portion of the allowance for credit losses that is allocated to each loan class (in thousands):

Residential

Commercial & Multi-family (1)

Cannabis

Related (2)

Construction (1)

Commercial
‎
Business (1) (3)

Business Express

Home

Equity (4)

Consumer

Total

Allowance for credit losses:

Beginning Balance, January 1, 2025

$

1,947

$

10,451

$

1,613

$

1,902

$

10,497

$

7,769

$

594

$

16

$

34,789

Charge-offs

-

(1,183)

(12,756)

-

(19,457)

(11,328)

-

-

(44,724)

Recoveries

75

-

-

-

7

1,533

-

-

1,615

Provision (benefit)

(246)

2,789

12,620

(1,234)

15,629

12,416

38

(1)

42,011

Ending Balance, December 31, 2025

$

1,776

$

12,057

$

1,477

$

668

$

6,676

$

10,390

$

632

$

15

$

33,691

Ending Balance attributable to loans:

Individually evaluated

$

-

$

2,657

$

-

$

-

$

2,938

$

998

$

-

$

-

$

6,593

Collectively evaluated

1,776

9,400

1,477

668

3,738

9,392

632

15

27,098

Ending Balance, December 31, 2025

$

1,776

$

12,057

$

1,477

$

668

$

6,676

$

10,390

$

632

$

15

$

33,691

Loans Receivables:

Individually evaluated

$

1,392

$

130,581

$

-

$

18,888

$

10,073

$

998

$

294

$

-

$

162,226

Collectively evaluated

225,316

1,910,187

69,293

49,633

158,386

73,864

74,038

3,580

2,564,297

Total Gross Loans:

$

226,708

$

2,040,768

$

69,293

$

68,521

$

168,459

$

74,862

$

74,332

$

3,580

$

2,726,523

(1) Excludes Cannabis related loans.

(2) Includes Commercial and multi-family, Construction, and Commercial business loans to borrowers involved in the cannabis industry.

(3) Excludes Business express loans.

(4) Includes Home equity lines of credit.

Note 6 - Loans Receivable and Allowance for Credit Losses (Continued)

The following tables present the activity in the allowance for credit losses on off-balance sheet exposures for the three and nine months ended September 30, 2026 and 2025.

Three Months Ended September 30,

2026

2025

(In Thousands)

Allowance for Credit Losses:

Beginning balance at July 1

$

286 

$

687 

Provision (benefit) for credit losses

68 

(207)

Ending balance at September 30

$

354 

$

480 

Nine Months Ended September 30,

2026

2025

(In Thousands)

Allowance for Credit Losses:

Beginning balance at January 1

$

830 

$

813 

Benefit for credit losses

(476)

(333)

Ending balance at September 30

$

354 

$

480 

The following table sets forth the delinquency status of total loans receivable as of September 30, 2026:

Greater Than

Greater Than

90 Days

30-59 Days

60-90 Days

90 Days

Total Past

Total Loans

Past Due

Past Due

Past Due

Past Due

Due

Current

Receivable

& Still Accruing

(In Thousands)

Residential one-to-four family

$

4,146 

$

161 

$

1,678 

$

5,985 

$

208,722 

$

214,707 

$

-

Commercial and multi-family (1)

18,094 

5,033 

14,307 

37,434 

1,716,108 

1,753,542 

-

Cannabis related (2)

-

-

-

-

4,070 

4,070 

-

Construction

-

-

-

-

13,434 

13,434 

-

Commercial business (3)

3,244 

285 

635 

4,164 

122,008 

126,172 

29 

Business express

1,810 

567 

-

2,377 

62,126 

64,503 

-

Home equity (4)

1,083 

719 

107 

1,909 

70,801 

72,710 

-

Consumer

300 

-

-

300 

2,076 

2,376 

-

Total

$

28,677 

$

6,765 

$

16,727 

$

52,169 

$

2,199,345 

$

2,251,514 

$

29 

(1) Excludes Cannabis related loans.

(2) Includes Commercial and multi-family loans to borrowers involved in the cannabis industry.

(3) Excludes Business express loans.

(4) Includes Home equity lines of credit.

The following table sets forth the delinquency status of total loans receivable at December 31, 2025:

Greater Than

30-59 Days

60-90 Days

90 Days

Total Past

Total Loans

Past Due

Past Due

Past Due

Due

Current

Receivable

(In Thousands)

Residential one-to-four family

$

4,342 

$

279 

$

594 

$

5,215 

$

221,493 

$

226,708 

Commercial and multi-family (1)

17,600 

3,296 

51,979 

72,875 

1,967,893 

2,040,768 

Cannabis related (2)

-

-

-

-

69,293 

69,293 

Construction (1)

-

-

4,897 

4,897 

63,624 

68,521 

Commercial business (1) (3)

8,583 

1,041 

2,975 

12,599 

155,860 

168,459 

Business express

1,961 

-

-

1,961 

72,901 

74,862 

Home equity (4)

1,289 

65 

231 

1,585 

72,747 

74,332 

Consumer

-

-

-

-

3,580 

3,580 

Total

$

33,775 

$

4,681 

$

60,676 

$

99,132 

$

2,627,391 

$

2,726,523 

(1) Excludes Cannabis related loans.

(2) Includes Commercial and multi-family, Construction, and Commercial business loans to borrowers involved in the cannabis industry.

(3) Excludes Business express loans.

(4) Includes Home equity lines of credit.


‎

Note 6 - Loans Receivable and Allowance for Credit Losses (Continued)

Modifications

The following tables present the amortized cost basis of loans to borrowers experiencing financial difficulty that were modified during the periods presented by loan category and type of concession granted and by payment status. There were no modifications during the three months ended September 30, 2026.

For the Nine Months Ended September 30, 2026

(In Thousands)

Number

Payment Delay

Term Extension

Rate Reduction

Total Principal

% of Total Class of Financing Receivable

Residential one-to-four family

1

$

-

$

-

$

332

$

332

0.15

%

Total loans

1

$

-

$

-

$

332

$

332

For the Nine Months Ended September 30, 2026

(In Thousands)

Current

30-59 Days Past Due

60-90 Days Past Due

Non-accrual

Total

Residential one-to-four family

$

332

$

-

$

-

$

-

$

332

Total

$

332

$

-

$

-

$

-

$

332

For the Three Months Ended September 30, 2025

(In Thousands)

Number

Payment Delay

Term Extension

Rate Reduction & Term Extension

Total Principal

% of Total Class of Financing Receivable

Residential

1

$

168

$

-

$

-

$

168

0.07

%

Commercial business

2

-

-

674

674

0.35

Business express

10

-

2,096

-

2,096

2.68

%

Total loans

13

$

168

$

2,096

$

674

$

2,938

For the Nine Months Ended September 30, 2025

(In Thousands)

Number

Payment Delay

Term Extension

Rate Reduction & Term Extension

Total Principal

% of Total Class of Financing Receivable

Residential

1 

$

168 

$

-

$

-

$

168 

0.07 

%

Commercial & multi-family

1 

-

25,643 

-

25,643 

1.23 

Commercial business

7 

-

985 

1,021 

2,006 

1.04 

Business express

96 

-

21,064 

-

21,064 

26.92 

%

Total loans

105 

$

168 

$

47,692 

$

1,021 

$

48,881 

For the Nine Months Ended September 30, 2025

(In Thousands)

Current

30-59 Days Past Due

60-90 Days Past Due

Non-accrual

Total

Residential

$

-

$

-

$

-

$

168 

$

168 

Commercial & multi-family

25,643 

-

-

-

25,643 

Commercial business

1,086 

-

-

920 

2,006 

Business express

19,924 

491 

-

649 

21,064 

Total

$

46,653 

$

491 

$

-

$

1,737 

$

48,881 

The Company monitors the performance of loans modified to borrowers experiencing financial difficulty to understand the effectiveness of the modification efforts.

For modified loans, a subsequent payment default occurs after management evaluates a borrower’s financial condition subsequent to modification and upon evaluating facts and circumstances determines the borrower is not adhering to the terms of the modification but no later than when a principal or interest payment is 90 days past due or the loan has been classified into non-accrual status during the reporting period.

There were no loans modified during the preceding twelve months that subsequently defaulted.

Note 6 - Loans Receivable and Allowance for Credit Losses (Continued)

The tables below set forth the amounts and types of non-accrual loans in the Bank’s loan portfolio at September 30, 2026 and December 31, 2025. Loans are placed on non-accrual status when they become more than 90 days delinquent, or earlier if the collection of principal and/or interest become doubtful.

As of September 30, 2026 and December 31, 2025, non-accrual loans differed from total loans past due 90 days or more because loans that were previously more than 90 days past due are maintained on non-accrual status for a minimum of six months or until the borrower has demonstrated their ability to satisfy the terms of the loan.

As of September 30, 2026

(In Thousands)

Non-accrual loans with an Allowance for Credit Losses

Non-accrual loans without an Allowance for Credit Losses

Total Non-accrual loans

Amortized Cost of Loans Greater Than 90 Days Past Due and Still Accruing

Residential one-to-four family

$

-

$

3,018 

$

3,018 

$

-

Commercial and multi-family

2,792 

14,699 

17,491 

-

Commercial business

-

1,724 

1,724 

29 

Home equity (1)

-

189 

189 

-

Total

$

2,792 

$

19,630 

$

22,422 

$

29 

(1) Includes Home equity lines of credit.

As of December 31, 2025

(In Thousands)

Non-accrual loans with an Allowance for Credit Losses

Non-accrual loans without an Allowance for Credit Losses

Total Non-accrual loans

Amortized Cost of Loans Greater Than 90 Days Past Due and Still Accruing

Residential one-to-four family

$

-

$

1,554 

$

1,554 

$

-

Commercial and multi-family

2,500 

49,659 

52,159 

-

Construction

-

4,897 

4,897 

-

Commercial business (1)

1,660 

2,065 

3,725 

-

Business express

626 

-

626 

-

Home equity (2)

-

294 

294 

-

Total

$

4,786 

$

58,469 

$

63,255 

$

-

(1) Excludes Business express loans.

(2) Includes Home equity lines of credit.

Criticized and Classified Assets

Company policies provide for a classification system for problem assets. Under this classification system, problem assets are classified as “substandard,” “doubtful,” or “loss.”

The Company’s internal credit risk grades are based on the definitions currently utilized by the banking regulatory agencies. The grades assigned and definitions are as follows, and loans graded excellent, above average, good and watch list (risk ratings 1-5) are treated as “pass” for grading purposes. The “criticized” risk rating (6) and the “classified” risk ratings (7-9) are detailed below:

6 – Special Mention- Loans currently performing but with potential weaknesses including adverse trends in borrower’s operations, credit quality, financial strength, or possible collateral deficiency.

7 – Substandard- Loans that are inadequately protected by current sound worth, paying capacity, and collateral support. Loans on “non-accrual” status. The loan needs special and corrective attention.

8 – Doubtful- Weaknesses in credit quality and collateral support make full collection improbable, but pending reasonable factors remain sufficient to defer the loss status.

9 – Loss- Continuance as a bankable asset is not warranted. However, this does not preclude future attempts at partial recovery.


‎

Note 6 - Loans Receivable and Allowance for Credit Losses (Continued)

The following table summarizes the Company's loans by year of origination and internally assigned credit risk rating at September 30, 2026 and gross charge-offs for the nine months ended September 30, 2026.

Loans by Year of Origination at September 30, 2026

2026

2025

2024

2023

2022

Prior

Revolving Loans

Revolving Loans to Term Loans

Total

Residential one-to-four family

Pass

$

5,722

$

8,855

$

11,760

$

13,971

$

39,328

$

128,214

$

-

$

-

$

207,850

Special Mention

-

-

-

-

2,657

846

-

-

3,503

Substandard

-

-

-

-

-

3,354

-

-

3,354

Total one-to-four family

$

5,722

$

8,855

$

11,760

$

13,971

$

41,985

$

132,414

$

-

$

-

$

214,707

Commercial and multi-family (1)

Pass

$

98,533

$

40,588

$

7,207

$

174,939

$

459,892

$

798,937

$

-

$

-

$

1,580,096

Special Mention

-

8,592

-

-

76,701

44,828

8,500

-

138,621

Substandard

-

-

-

-

1,005

33,680

140

-

34,825

Total Commercial and multi-family

$

98,533

$

49,180

$

7,207

$

174,939

$

537,598

$

877,445

$

8,640

$

-

$

1,753,542

Cannabis related (2)

Pass

$

4,070

$

-

$

-

$

-

$

-

$

-

$

-

$

-

$

4,070

Special Mention

-

-

-

-

-

-

-

-

-

Substandard

-

-

-

-

-

-

-

-

-

Total Cannabis related

$

4,070

$

-

$

-

$

-

$

-

$

-

$

-

$

-

$

4,070

Construction (1)

Pass

$

7,826

$

1,244

$

5

$

-

$

206

$

-

$

4,153

$

-

$

13,434

Special Mention

-

-

-

-

-

-

-

-

-

Substandard

-

-

-

-

-

-

-

-

-

Total Construction

$

7,826

$

1,244

$

5

$

-

$

206

$

-

$

4,153

$

-

$

13,434

Commercial business (1) (3)

Pass

$

3,593

$

-

$

7,045

$

1,968

$

4,821

$

12,919

$

82,756

$

-

$

113,102

Special Mention

-

-

-

-

-

554

6,459

-

7,013

Substandard

-

-

-

-

-

4,233

1,824

-

6,057

Total Commercial business

$

3,593

$

-

$

7,045

$

1,968

$

4,821

$

17,706

$

91,039

$

-

$

126,172

Business express

Pass

$

-

$

-

$

-

$

-

$

-

$

-

$

-

$

60,597

$

60,597

Special Mention

-

-

-

-

-

-

-

2,212

2,212

Substandard

-

-

-

-

-

-

-

1,694

1,694

Total Business express

$

-

$

-

$

-

$

-

$

-

$

-

$

-

$

64,503

$

64,503

Home equity (4)

Pass

$

769

$

1,479

$

35

$

2,930

$

1,152

$

4,170

$

57,560

$

3,342

$

71,437

Special Mention

-

-

-

-

-

39

1,045

-

1,084

Substandard

-

-

-

-

12

95

27

55

189

Total Home equity

$

769

$

1,479

$

35

$

2,930

$

1,164

$

4,304

$

58,632

$

3,397

$

72,710

Consumer

Pass

$

407

$

1,200

$

200

$

10

$

251

$

-

$

8

$

-

$

2,076

Special Mention

-

-

-

300

-

-

-

-

300

Substandard

-

-

-

-

-

-

-

-

-

Total Consumer

$

407

$

1,200

$

200

$

310

$

251

$

-

$

8

$

-

$

2,376

Total Pass

$

120,920

$

53,366

$

26,252

$

193,818

$

505,650

$

944,240

$

144,477

$

63,939

$

2,052,662

Total Special Mention

$

-

$

8,592

$

-

$

300

$

79,358

$

46,267

$

16,004

$

2,212

$

152,733

Total Substandard

$

-

$

-

$

-

$

-

$

1,017

$

41,362

$

1,991

$

1,749

$

46,119

Total Loans

$

120,920

$

61,958

$

26,252

$

194,118

$

586,025

$

1,031,869

$

162,472

$

67,900

$

2,251,514

Gross charge-offs

$

765

$

-

$

-

$

10,099

$

35,084

$

38,173

$

3,351

$

14,994

$

102,466

(1) Excludes Cannabis related loans.

(2) Includes Commercial and multi-family, Construction, and Commercial business loans to borrowers involved in the cannabis industry.

(3) Excludes Business express loans.

(4) Includes Home equity lines of credit.

Note 6 - Loans Receivable and Allowance for Credit Losses (Continued)

The following table summarizes the Company's loans by year of origination and internally assigned credit risk rating and gross charge-offs for the year ended December 31, 2025.

Loans by Year of Origination at December 31, 2025

2025

2024

2023

2022

2021

Prior

Revolving Loans

Revolving Loans to Term Loans

Total

Residential one-to-four family

Pass

$

10,255 

$

11,887 

$

15,164 

$

43,691 

$

33,586 

$

107,069 

$

-

$

-

$

221,652 

Special Mention

-

-

-

1,802 

910 

790 

-

-

3,502 

Substandard

-

-

-

-

445 

1,109 

-

-

1,554 

Total one-to-four family

$

10,255 

$

11,887 

$

15,164 

$

45,493 

$

34,941 

$

108,968 

$

-

$

-

$

226,708 

Commercial and multi-family (1)

Pass

$

50,098 

$

8,293 

$

184,486 

$

613,331 

$

151,205 

$

773,732 

$

8,760 

$

-

$

1,789,905 

Special Mention

-

-

-

28,029 

11,307 

58,141 

140 

-

97,617 

Substandard

-

-

1,633 

68,011 

18,795 

64,807 

-

-

153,246 

Total Commercial and multi-family

$

50,098 

$

8,293 

$

186,119 

$

709,371 

$

181,307 

$

896,680 

$

8,900 

$

-

$

2,040,768 

Cannabis related (2)

Pass

$

-

$

-

$

-

$

8,385 

$

2,067 

$

7,958 

$

8,050 

$

-

$

26,460 

Special Mention

-

-

18,981 

17,552 

5,442 

-

858 

-

42,833 

Substandard

-

-

-

-

-

-

-

-

-

Total Cannabis related

$

-

$

-

$

18,981 

$

25,937 

$

7,509 

$

7,958 

$

8,908 

$

-

$

69,293 

Construction (1)

Pass

$

917 

$

2,004 

$

15,752 

$

19,460 

$

4,403 

$

-

$

4,803 

$

-

$

47,339 

Special Mention

-

-

2,294 

-

-

-

-

-

2,294 

Substandard

-

-

-

15,715 

2,587 

586 

-

-

18,888 

Total Construction

$

917 

$

2,004 

$

18,046 

$

35,175 

$

6,990 

$

586 

$

4,803 

$

-

$

68,521 

Commercial business (1) (3)

Pass

$

-

$

7,388 

$

1,995 

$

4,829 

$

1,039 

$

24,455 

$

93,029 

$

-

$

132,735 

Special Mention

-

-

-

-

1,458 

2,358 

18,153 

-

21,969 

Substandard

-

-

-

-

-

2,047 

11,708 

-

13,755 

Total Commercial business

$

-

$

7,388 

$

1,995 

$

4,829 

$

2,497 

$

28,860 

$

122,890 

$

-

$

168,459 

Business express

Pass

$

-

$

-

$

-

$

-

$

-

$

-

$

$

71,843 

$

71,843 

Special Mention

-

-

-

-

-

-

2,021 

2,021 

Substandard

-

-

-

-

-

-

397 

601 

998 

Total Business express

$

-

$

-

$

-

$

-

$

-

$

-

$

397 

$

74,465 

$

74,862 

Home equity (4)

Pass

$

1,796 

$

164 

$

3,293 

$

1,246 

$

396 

$

4,914 

$

57,357 

$

4,319 

$

73,485 

Special Mention

-

-

-

-

-

42 

511 

-

553 

Substandard

-

-

-

-

-

114 

30 

150 

294 

Total Home equity

$

1,796 

$

164 

$

3,293 

$

1,246 

$

396 

$

5,070 

$

57,898 

$

4,469 

$

74,332 

Consumer

Pass

$

1,824 

$

272 

$

1,106 

$

290 

$

2 

$

80 

$

6 

$

-

$

3,580 

Special Mention

-

-

-

-

-

-

-

-

-

Substandard

-

-

-

-

-

-

-

-

-

Total Consumer

$

1,824 

$

272 

$

1,106 

$

290 

$

2 

$

80 

$

6 

$

-

$

3,580 

Total Pass

$

64,890 

$

30,008 

$

221,796 

$

691,232 

$

192,698 

$

918,208 

$

172,005 

$

76,162 

$

2,366,999 

Total Special Mention

$

-

$

-

$

21,275 

$

47,383 

$

19,117 

$

61,331 

$

19,662 

$

2,021 

$

170,789 

Total Substandard

$

-

$

-

$

1,633 

$

83,726 

$

21,827 

$

68,663 

$

12,135 

$

751 

$

188,735 

Total Loans

$

64,890 

$

30,008 

$

244,704 

$

822,341 

$

233,642 

$

1,048,202 

$

203,802 

$

78,934 

$

2,726,523 

Gross charge-offs

$

-

$

-

$

-

$

12,836 

$

282 

$

3,848 

$

18,166 

$

9,592 

$

44,724 

(1) Excludes Cannabis related loans.

(2) Includes Commercial and multi-family, Construction, and Commercial business loans to borrowers involved in the cannabis industry.

(3) Excludes Business express loans.

(4) Includes Home equity lines of credit.

a